INTECH INVESTMENT MANAGEMENT LLC

Position in PCRX — Pacira BioSciences, Inc.

CIK 1086318 WEST PALM BEACH, FL

Back to PCRX Full portfolio

Position in PCRX

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$701,978

-$3,612,606 QoQ

Shares Held

31,061

-81.4% QoQ

Ownership

0.079%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

INTECH INVESTMENT MANAGEMENT LLC holds $94,314,635 across 29 Drug Manufacturers - Specialty & Generic names. PCRX ranks #14 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	311,871	$36,866,270
2	TEVA	Teva Pharmaceutical Industries Ltd	478,939	$14,425,641
3	UTHR	UNITED THERAPEUTICS Corp	20,744	$12,300,776
4	NBIX	Neurocrine Biosciences Inc	86,315	$11,371,137
5	LNTH	Lantheus Holdings, Inc.	44,826	$3,400,052
6	INDV	Indivior Pharmaceuticals, Inc.	88,945	$2,711,043
7	ALKS	Alkermes plc.	60,967	$2,155,793
8	SUPN	Supernus Pharmaceuticals, Inc.	38,984	$2,015,082

All Filings in PCRX

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$701,978	31,061	-81.4%	Shares	Sole	2026-05-08
2025-12-31	$4,314,584	166,715	+164.1%	Shares	Sole	2026-02-10
2025-09-30	$1,626,653	63,122	+187.1%	Shares	Sole	2025-11-12
2025-06-30	$525,441	21,985	0.0%	Shares	Sole	2025-08-08
2025-03-31	$546,327	21,985	+29.6%	Shares	Sole	2025-05-20
2024-12-31	$319,658	16,967	+33.4%	Shares	Sole	2025-02-11
2024-09-30	$191,375	12,716	—	Shares	Sole	2024-11-08
No filing history on record for this holder in this stock.